If you’ve come across Fraboc while researching breast cancer or family history, the term refers to an Australian clinical risk-assessment tool rather than a breast cancer diagnosis, treatment or genetic test.

More precisely known as FRA-BOC, or Familial Risk Assessment-Breast and Ovarian Cancer, the tool was developed for health professionals to assess a patient’s risk of breast and ovarian cancer using information about their family history. Cancer Australia confirms that FRA-BOC is no longer available on its website, with newer risk-assessment tools now being used instead.

The reason Fraboc remains relevant is that the questions behind it still matter. A family history of breast cancer can sometimes indicate a higher-than-average risk, particularly when several relatives were affected, cancer occurred at a young age, or breast and ovarian cancers appear together in a family.

What Was Fraboc?

FRA-BOC was designed to help doctors and nurses make sense of family patterns involving breast and ovarian cancer.

It wasn’t intended to tell someone that they would or wouldn’t develop cancer. Instead, it helped health professionals estimate risk and determine whether a woman might need routine screening, closer monitoring or referral to a specialist service.

The assessment focused heavily on family history. That could include which relatives had cancer, whether they were on the same side of the family, the type of cancer involved and the age at which relatives were diagnosed.

This distinction is important. Having a parent, sibling or another relative with breast cancer doesn’t automatically mean someone has an inherited cancer gene or will develop breast cancer themselves.

Cancer Australia says less than 5% of breast cancer cases overall are caused by an inherited gene fault. However, a strong family history can still be an important reason for a more detailed risk assessment.

Why Family History Matters

Family history can provide clues about both inherited genetics and patterns of cancer occurring within a family.

Some inherited gene changes, including changes involving BRCA1 and BRCA2, can substantially increase the risk of breast and ovarian cancers. But genetics isn’t the only explanation for a family pattern. Families can also share environmental, reproductive and lifestyle factors.

A person’s overall risk can therefore be influenced by several things at once.

Cancer Australia lists family history and genetic predisposition alongside factors such as breast density, reproductive history, alcohol consumption, body weight and physical activity.

That is why a family-history assessment is more useful when it considers the wider picture rather than focusing on one relative.

Which Family Patterns Can Raise Concern?

Certain patterns are more significant than a single older relative developing breast cancer.

Earlier Australian guidance used family-history categories to identify women at average, moderately increased and potentially high risk. Factors associated with greater concern included multiple relatives with breast or ovarian cancer, breast cancer diagnosed at a young age, cancer affecting both breasts, breast and ovarian cancer occurring in the same person, male breast cancer and a known high-risk gene mutation in the family.

The side of the family also matters.

People sometimes think only their mother’s family history is relevant. That’s incorrect. An inherited gene variant can come from either parent, so information about both the maternal and paternal sides can be useful when assessing risk.

For someone preparing for a discussion with a GP, useful information may include:

• Which relatives had breast or ovarian cancer
• Their relationship to you
• The age at which they were diagnosed
• Whether cancer affected one or both breasts
• Whether any male relatives had breast cancer
• Whether anyone in the family had ovarian cancer
• Whether genetic testing has identified a BRCA or other cancer-related gene variant

You don’t need to know every detail before speaking with a doctor. Even incomplete family information can be a starting point.

Fraboc Was Not a Genetic Test

One common misunderstanding is that Fraboc itself tested for breast cancer genes.

It didn’t.

FRA-BOC was a risk assessment tool based on family history. Genetic testing is a separate process and may be considered when someone’s family history suggests a possible inherited cancer predisposition.

Cancer Australia notes that women with a strong family history may be referred to a family cancer clinic, where they can receive a more precise risk assessment and advice about whether genetic testing is appropriate.

Genetic testing also isn’t automatically recommended simply because someone has a relative who had breast cancer. The decision depends on the person’s family pattern and clinical circumstances.

Is Fraboc Still Available?

No. Cancer Australia’s current breast cancer information states that the Familial Risk Assessment – Breast and Ovarian Cancer (FRA-BOC) tool is no longer available on its website. The organisation now points people toward more up-to-date risk assessment options.

One of those options is iPrevent, a validated breast cancer risk-assessment and risk-management decision-support tool. It is designed to support discussions between women and their doctors about prevention and screening.

This means someone searching for Fraboc today may be looking at an older medical document, archived information or historical guidance.

The underlying idea hasn’t disappeared. It has simply been incorporated into newer approaches to breast cancer risk assessment.

What Has Replaced Fraboc?

There isn’t necessarily a single one-for-one replacement in every clinical situation.

Cancer Australia currently recommends iPrevent as a validated tool for assessing breast cancer risk. Other recognised tools, including Tyrer-Cuzick and CanRisk, may also be used depending on the clinical situation and healthcare setting.

The Australian Government’s current guidance for GPs says validated risk tools such as iPrevent, Tyrer-Cuzick or CanRisk can help calculate individual breast cancer risk and support discussions about prevention and screening.

For people with a particularly strong family history, a family cancer service may be more appropriate than relying on an online calculator alone.

Does Having a Family History Mean You Will Get Breast Cancer?

No. This is perhaps the most important point when interpreting any family-history assessment.

Having a relative with breast cancer can increase risk, but it doesn’t mean cancer is inevitable. Likewise, someone without a known family history can still develop breast cancer.

Risk is a probability, not a prediction of an individual’s future.

Cancer Australia also cautions that having one or more risk factors does not mean a person will develop cancer. Many people have recognised risk factors and never develop the disease, while others develop cancer without an obvious risk factor.

That’s why the result of a risk assessment should be discussed in context with a healthcare professional.

What Should You Do If Breast Cancer Runs in Your Family?

If several relatives have had breast or ovarian cancer, or if someone was diagnosed unusually young, it is reasonable to discuss the family history with a GP.

The doctor may ask questions about relatives, ages at diagnosis and types of cancer. Depending on the pattern, they may recommend a formal risk assessment or referral to a specialist family cancer service.

For some women at increased risk, additional screening or risk-reduction strategies may be considered. These decisions are individual and depend on the estimated level of risk.

Current Australian guidance also recognises that breast density can affect both breast cancer risk and the ability of mammography to detect cancer. The Australian Government recommends that breast density be considered alongside other risk factors rather than viewed in isolation.

What About Breast Cancer Screening?

Screening recommendations depend on age, symptoms, personal risk and the healthcare system involved.

In Australia, BreastScreen Australia provides population-based mammography screening, while women with higher risk may need an individualised screening plan. The Australian Government says women who know they are at higher risk should speak with their doctor rather than simply waiting until they become eligible for routine population screening.

It’s also important not to confuse screening with investigating symptoms.

If someone notices a new breast lump, nipple change, unusual discharge, skin dimpling, redness or another persistent change, they should speak with a doctor. Cancer Australia advises people to seek medical attention for unusual breast or nipple changes rather than waiting for their next screening appointment.

What Happens Next for Someone With a Strong Family History?

The next step is usually a proper clinical assessment rather than trying to interpret family history alone.

A GP may review the family pattern and use a validated risk tool. If the history suggests a potentially inherited risk, referral to a family cancer clinic or genetics service may be appropriate.

For some people, the result may simply confirm that their risk is close to average. For others, it may lead to more frequent screening, genetic counselling or consideration of risk-reducing options.

The important thing is that the assessment turns a vague concern into a clearer plan.

Final Takes

Fraboc is best understood as an older Australian tool that helped health professionals assess breast and ovarian cancer risk from family history. Although FRA-BOC is no longer available through Cancer Australia, the issue it addressed remains highly relevant.

Family history can sometimes reveal an increased risk, especially when cancers occur in several relatives, at younger ages or alongside ovarian cancer. But having a family history does not mean a person is destined to develop breast cancer.

Today, newer tools such as iPrevent are used to support more detailed risk discussions. Anyone concerned about inherited breast cancer risk should bring their family history to a GP, who can determine whether further assessment or specialist referral is appropriate.

FAQs

What is Fraboc?

Fraboc, also known as FRA-BOC (Familial Risk Assessment – Breast and Ovarian Cancer), was a tool used by healthcare professionals to assess a person’s risk of breast and ovarian cancer based on family history.

Is Fraboc still available?

No. The original FRA-BOC tool is no longer available through Cancer Australia. Healthcare professionals now use newer risk assessment tools and methods to evaluate breast cancer risk.

Does having a family history of breast cancer mean I will get cancer?

No. A family history can increase risk, but it does not mean you will definitely develop breast cancer. Many people with a family history never develop the disease.

Which family members are important when assessing breast cancer risk?

Doctors typically consider the cancer history of close relatives, including parents, siblings, children, grandparents, aunts, uncles, and cousins from both sides of the family.

What information should I gather before speaking to a doctor?

Helpful details include which relatives had cancer, the type of cancer, their age at diagnosis, and whether any family members have undergone genetic testing.

Can Fraboc detect BRCA gene mutations?

No. Fraboc was not a genetic test. It assessed risk based on family history. Genetic testing for BRCA1, BRCA2, and other inherited gene mutations is a separate medical process.

Who should consider a formal breast cancer risk assessment?

People with multiple relatives affected by breast or ovarian cancer, early-age cancer diagnoses in the family, or known inherited cancer-related gene mutations may benefit from a formal risk assessment.

What should I do if I am concerned about my family history?

Speak with your GP or healthcare provider. They can review your family history, assess your risk, and determine whether additional screening, genetic counselling, or specialist referral is appropriate.